Pages that link to "Q24302047"
Jump to navigation
Jump to search
The following pages link to Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake (Q24302047):
Displaying 50 items.
- Thrombospondin 1 (Q3822573) (← links)
- CD36 molecule (Q4035577) (← links)
- Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis (Q24316639) (← links)
- CD47 regulates bone mass and tumor metastasis to bone (Q24651925) (← links)
- Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling (Q24657627) (← links)
- Regulation of signal transduction by reactive oxygen species in the cardiovascular system (Q28391569) (← links)
- Amyloid-β Inhibits No-cGMP Signaling in a CD36- and CD47-Dependent Manner (Q28476620) (← links)
- The evolution of thrombospondins and their ligand-binding activities (Q28744006) (← links)
- Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow. (Q30482804) (← links)
- Molecular regulation of tumor angiogenesis and perfusion via redox signaling (Q33572306) (← links)
- E2F-1 Directly Regulates Thrombospondin 1 Expression (Q33728451) (← links)
- Post-translational myristoylation: Fat matters in cellular life and death (Q34148521) (← links)
- The complex and important cellular and metabolic functions of saturated fatty acids (Q34280533) (← links)
- Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. (Q34385843) (← links)
- Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP. (Q34516854) (← links)
- Expressed sequence tags for bovine muscle satellite cells, myotube formed-cells and adipocyte-like cells (Q35041490) (← links)
- Effect and mechanism of thrombospondin-1 on the angiogenesis potential in human endothelial progenitor cells: an in vitro study (Q35088607) (← links)
- Modulation of phosphorylation of tocopherol and phosphatidylinositol by hTAP1/SEC14L2-mediated lipid exchange (Q35199264) (← links)
- The thrombospondins. (Q35230013) (← links)
- Interaction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy (Q35613320) (← links)
- Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. (Q35902676) (← links)
- ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer (Q36060215) (← links)
- Original insights on thrombospondin-1-related antireceptor strategies in cancer (Q36221374) (← links)
- Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells. (Q36496361) (← links)
- The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis (Q36632900) (← links)
- Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease (Q36725128) (← links)
- CD47 signaling pathways controlling cellular differentiation and responses to stress (Q36771076) (← links)
- CD47: a new target in cardiovascular therapy. (Q36908751) (← links)
- Thrombospondin-1: a physiological regulator of nitric oxide signaling (Q36926096) (← links)
- Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling. (Q36955405) (← links)
- Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses. (Q37036482) (← links)
- Thrombospondins in cancer (Q37056249) (← links)
- A Common CD36 Variant Influences Endothelial Function and Response to Treatment with Phosphodiesterase 5 Inhibition (Q37057946) (← links)
- The use of CD47-modified biomaterials to mitigate the immune response (Q37107151) (← links)
- The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension (Q37139980) (← links)
- Exercise training and peripheral arterial disease (Q37157213) (← links)
- Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina. (Q37200250) (← links)
- Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies (Q37385797) (← links)
- Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation (Q37400455) (← links)
- Repeating structures of the major staphylococcal autolysin are essential for the interaction with human thrombospondin 1 and vitronectin (Q37583476) (← links)
- The role of thrombospondins in wound healing, ischemia, and the foreign body reaction (Q37618614) (← links)
- Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): In silico Investigation (Q37625434) (← links)
- Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow. (Q37697630) (← links)
- Compartmentalized nitric oxide signaling in the resistance vasculature (Q38509844) (← links)
- Thrombospondin-1, free radicals, and the coronary microcirculation: the aging conundrum (Q38648723) (← links)
- Regulation of cellular redox signaling by matricellular proteins in vascular biology, immunology, and cancer (Q38656989) (← links)
- Pneumococcal Adhesins PavB and PspC Are Important for the Interplay with Human Thrombospondin-1. (Q38884066) (← links)
- Role of thrombospondin 1 in liver diseases. (Q38918913) (← links)
- Anti-angiogenesis effect of 3'-sulfoquinovosyl-1'-monoacylglycerol via upregulation of thrombospondin 1. (Q39225511) (← links)
- Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease (Q39284030) (← links)